Cargando…

Correction to: Implementation of Ticagrelor Reduced Mortality in Routine Clinical Care: Evidence From a Natural Experiment Including 109 995 Patients With Myocardial Infarction in Sweden

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227219/ https://www.ncbi.nlm.nih.gov/pubmed/37119079 http://dx.doi.org/10.1161/JAHA.122.027679

Ejemplares similares

Implementation of Ticagrelor Reduced Mortality in Routine Clinical Care: Evidence From a Natural Experiment Including 109 995 Patients With Myocardial Infarction in Sweden
por: Johannesen, Kasper, et al.
Publicado: (2023)

Effects of Ticagrelor on Myocardial Infarct Size
por: Hahn, Joo-Yong
Publicado: (2017)

Will Ticagrelor Help Post-Myocardial Infarction ‘Healing’?
por: Park, Kyung Woo
Publicado: (2019)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
por: Volney, Candice, et al.
Publicado: (2019)

Ticagrelor-Induced Torsades de Pointes following Myocardial Infarction
por: Bu, Seong Hyeon, et al.
Publicado: (2022)

Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS–TIMI 54
por: Bonaca, Marc P., et al.
Publicado: (2018)

Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction
por: Scanavini-Filho, Marco Antonio, et al.
Publicado: (2022)

Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
por: Peasah, Samuel K., et al.
Publicado: (2023)

Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor
por: Adamski, Piotr, et al.
Publicado: (2022)

Low platelet reactivity in patients with myocardial infarction treated with aspirin plus ticagrelor
por: Costa, Thiago Guarato Rodrigues, et al.
Publicado: (2022)

Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
por: Tjerkaski, Jonathan, et al.
Publicado: (2023)

Correction to Lancet Oncol 2016; 17: 109
Publicado: (2016)

Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry
por: Basra, Sukhdeep S., et al.
Publicado: (2018)

The introduction of ticagrelor is associated with lower rates of recurrent ischemic stroke after myocardial infarction
por: Henriksson, Robin, et al.
Publicado: (2019)

Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction
por: Akşit, Ercan, et al.
Publicado: (2020)

Safety and feasibility of low‐dose ticagrelor in patients with ST‐segment elevation myocardial infarction
por: Wang, Yanbo, et al.
Publicado: (2020)

Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel
por: Samman, Karla N., et al.
Publicado: (2021)

Using Ticagrelor to Prevent Recurrent Type 1 and Type 2 Myocardial Infarctions: Boon or Bane?
por: Bittl, John A.
Publicado: (2018)

Long‐Term Ticagrelor Versus Prasugrel Pharmacodynamics in Patients With ST‐Segment–Elevation Myocardial Infarction
por: Cassese, Salvatore, et al.
Publicado: (2020)

Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST‐Segment–Elevation Myocardial Infarctions
por: Schmucker, Johannes, et al.
Publicado: (2019)

Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction: Bleeding Avoidance First and Foremost
por: Cao, Davide, et al.
Publicado: (2021)

Clinical Outcomes of Ticagrelor in Korean Patients with Acute Myocardial Infarction without High Bleeding Risk
por: Park, Keun-Ho, et al.
Publicado: (2021)

Efficacy and safety of ticagrelor versus clopidogrel in patients with non-ST-elevation myocardial infarction in Taiwan
por: Lee, Chih-Kuo, et al.
Publicado: (2021)

Ticagrelor to Reduce Myocardial Injury in Patients With High-Risk Coronary Artery Plaque
por: Moss, Alastair J., et al.
Publicado: (2020)

GH Secretory Dynamics and Responsiveness to SMS 201-995 Treatment in Acromegaly
por: Kim, Sung Woon, et al.
Publicado: (1988)

The Effect of Long Acting Somatostatin Analogue SMS 201-995 in Acromegaly
por: Choi, Chul Joon, et al.
Publicado: (1987)

995 Comparing the Clinical Presentation of Viral Causes of Pediatric Acute Gastroenteritis
por: Halasa, Natasha, et al.
Publicado: (2014)

Impact of opioids on P2Y(12) receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial
por: Tavenier, Anne H, et al.
Publicado: (2020)

Correction: Exercise Training Reduces Cardiac Dysfunction and Remodeling in Ovariectomized Rats Submitted to Myocardial Infarction
Publicado: (2015)

Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction
por: Henriksson, Robin, et al.
Publicado: (2019)

Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel
por: Gasecka, Aleksandra, et al.
Publicado: (2020)

Hospitalization for Myocardial Infarction with Ticagrelor or Clopidogrel in Patients with Acute Coronary Syndrome: An On-Treatment Comparative Effectiveness Analysis
por: Olufade, Tope, et al.
Publicado: (2021)

Thrombogenicity and endothelial progenitor cells function during Acute myocardial infarction - comparison of Prasugrel versus Ticagrelor
por: Wiessman, Maya, et al.
Publicado: (2023)

Safety of Bivalirudin Combined with Ticagrelor in the Emergency PCI in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Wang, Zheng-Dong, et al.
Publicado: (2022)

Ticagrelor Can Regulate the Ion Channel Characteristics of Superior Cervical Ganglion Neurons after Myocardial Infarction
por: Cheng, Lijun, et al.
Publicado: (2023)

Correction: Effects of night-time and weekend admissions on in-hospital mortality in acute myocardial infarction patients in Japan
por: Mizuno, Seiko, et al.
Publicado: (2019)

Comparison of the Infarct Size between the Loading of Ticagrelor and Clopidogrel in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Yun, Kyeong Ho, et al.
Publicado: (2017)

Reducing Microvascular Dysfunction in Revascularized Patients with ST-Elevation Myocardial Infarction by Off-Target Properties of Ticagrelor versus Prasugrel. Rationale and Design of the REDUCE-MVI Study
por: Janssens, Gladys N., et al.
Publicado: (2016)

Correction: Testosterone deficiency reduces the effects of late cardiac remodeling after acute myocardial infarction in rats
por: Fernandes Corrêa, Rafaela de Araujo, et al.
Publicado: (2019)

Age- and Sex-Specific In-Hospital Mortality after Myocardial Infarction in Routine Clinical Practice
por: Ani, Chizobam, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_bjmaoe5tiu93j3qqs7qeavs3f9